SSP
NUVB icon

Sixth Street Partners’s Nuvation Bio NUVB Stock Holding History

Sixth Street Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
+2,058,870
New +$10.1M ﹤0.01% 2084

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sixth Street Partners's NUVB Position: Q2 2026 in Review

Sixth Street Partners opened a new position in Nuvation Bio (NUVB) in Q2 2026: 2,058,870 shares worth $11.7M. The stake represents ﹤0.01% of the portfolio and ranks #2084 among its holdings.

178 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Sixth Street Partners held 2,058,870 shares of Nuvation Bio worth $11.7M as of Q2 2026.
  • Nuvation Bio was a new Sixth Street Partners position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Sixth Street Partners's portfolio in Q2 2026, its #2084 holding.
  • 178 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Sixth Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.